Author

C. Gravesteijn

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

A. Brouwers-Vos· 1 shared A. Rodriguez Lopez· 1 shared E. Vellenga· 1 shared G. Huls· 1 shared H. Maat· 1 shared J. J. Schuringa· 1 shared J. Jaques· 1 shared M. P. de Vries· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Brouwers-Vos

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivJul 9, 2019

USP7 as part of non-canonical PRC1.1 is a druggable target in leukemia

H. Maat, J. Jaques, A. Rodriguez Lopez…·J. J. Schuringa

This study identifies USP7 as a therapeutic target in leukemia, particularly in TP53-mutated AML, by showing its role in non-canonical PRC1.1 complex stability and function.

DOI 10.1016/j.isci.2021.102435

humanDNA methylation